Literature DB >> 33542185

Inhibition of long non-coding RNA XIST upregulates microRNA-149-3p to repress ovarian cancer cell progression.

Rong Jiang1, Hongyu Zhang1, Jinhua Zhou1, Juan Wang1, Yuejuan Xu1, He Zhang1, Yanzheng Gu2,3,4, Fengqing Fu2,3,4, Yu Shen2,3,4, Guangbo Zhang2,3,4, Lanlan Feng5, Xueguang Zhang2,3,4, Youguo Chen6, Fangrong Shen7.   

Abstract

Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) play critical roles in human diseases. We aimed to clarify the role of lncRNA X-inactive specific transcript (XIST)/miR-149-3p/forkhead box P3 (FOXP3) axis in ovarian cancer (OC) cell growth. XIST, miR-149-3p and FOXP3 expression in OC tissues and cell lines was assessed, and the predictive role of XIST in prognosis of OC patients was analyzed. The OC cell lines were screened and accordingly treated with silenced/overexpressed XIST plasmid or miR-149-3p mimic/inhibitor, and then the proliferation, invasion, migration, colony formation ability, apoptosis, and cell cycle distribution of OC cells were measured. Effect of altered XIST and miR-149-3p on tumor growth in vivo was observed. Online website prediction and dual luciferase reporter gene were implemented to detect the targeting relationship of lncRNA XIST, miR-149-3p, and FOXP3. XIST and FOXP3 were upregulated, whereas miR-149-3p was downregulated in OC tissues and cells. High XIST expression indicated a poor prognosis of OC. Inhibition of XIST or elevation of miR-149-3p repressed proliferation, invasion, migration, and colony formation ability, and promoted apoptosis and cell cycle arrest of HO-8910 cells. In SKOV3 cells upon treatment of overexpressed XIST or reduction of miR-149-3p, there exhibited an opposite tendency. Based on online website prediction, dual luciferase reporter gene, and RNA pull-down assays, we found that there was a negative relationship between XIST and miR-149-3p, and miR-149-3p downregulated FOXP3 expression. This study highlights that knockdown of XIST elevates miR-149-3p expression to suppress malignant behaviors of OC cells, thereby inhibiting OC development.

Entities:  

Year:  2021        PMID: 33542185      PMCID: PMC7862378          DOI: 10.1038/s41419-020-03358-0

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  30 in total

1.  Carcinoma of the fallopian tube. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

Authors:  A P M Heintz; F Odicino; P Maisonneuve; M A Quinn; J L Benedet; W T Creasman; H Y S Ngan; S Pecorelli; U Beller
Journal:  Int J Gynaecol Obstet       Date:  2006-11       Impact factor: 3.561

2.  Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.

Authors:  H-B Qiu; K Yang; H-Y Yu; M Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-10       Impact factor: 3.507

3.  MicroRNA-149 suppresses the proliferation and increases the sensitivity of ovarian cancer cells to cisplatin by targeting X-linked inhibitor of apoptosis.

Authors:  Lin Sun; Ruixia Zhai; Li Zhang; Shuping Zhao
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

Review 4.  Ovarian Cancer: An Integrated Review.

Authors:  Christine Stewart; Christine Ralyea; Suzy Lockwood
Journal:  Semin Oncol Nurs       Date:  2019-03-11       Impact factor: 2.315

5.  Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

Authors:  Dengke Yang; Guang Du; An Xu; Xuetao Xi; Dong Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer.

Authors:  Hai-Yan Zhang; Hong Sun
Journal:  Cancer Lett       Date:  2009-07-22       Impact factor: 8.679

7.  MicroRNA-214 Suppresses Ovarian Cancer by Targeting β-Catenin.

Authors:  Yang Liu; Jie Lin; Shujuan Zhai; Chunyi Sun; Changjun Xu; Honglin Zhou; Huijin Liu
Journal:  Cell Physiol Biochem       Date:  2018-02-21

8.  miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer.

Authors:  Jia-Peng Li; Hui-Min Zhang; Mei-Jun Liu; Yuan Xiang; Hui Li; Feng Huang; Han-Han Li; Zhou-Tong Dai; Chao Jiang Gu; Xing-Hua Liao; Tong-Cun Zhang
Journal:  J Cell Biochem       Date:  2020-01-06       Impact factor: 4.429

9.  Long Noncoding RNA FEZF1-AS1 Promotes Proliferation and Inhibits Apoptosis in Ovarian Cancer by Activation of JAK-STAT3 Pathway.

Authors:  Xia Zhao; Zhaofang Cheng; Jian Wang
Journal:  Med Sci Monit       Date:  2018-11-12

10.  Up-regulated lncRNA XIST contributes to progression of cervical cancer via regulating miR-140-5p and ORC1.

Authors:  Xing Chen; Dongsheng Xiong; Liya Ye; Kai Wang; Lingfei Huang; Shuangshuang Mei; Jinhong Wu; Shanshan Chen; Xiaoli Lai; Lingzhi Zheng; Meifen Wang
Journal:  Cancer Cell Int       Date:  2019-02-28       Impact factor: 5.722

View more
  7 in total

1.  A novel imatinib-upregulated long noncoding RNA plays a critical role in inhibition of tumor growth induced by Abl oncogenes.

Authors:  Yun Ma; Guijie Guo; Tingting Li; Faxin Wen; Jianling Yang; Biao Chen; Xuefei Wang; Ji-Long Chen
Journal:  Mol Cancer       Date:  2022-01-03       Impact factor: 27.401

2.  Long non-coding RNA TRPM2 antisense RNA as a potential therapeutic target promotes tumorigenesis and metastasis in esophageal cancer.

Authors:  Wei Wang; Yukai Dai; Xin Yang; Xinming Xiong
Journal:  Bioengineered       Date:  2022-02       Impact factor: 6.832

Review 3.  Long noncoding RNA XIST: Mechanisms for X chromosome inactivation, roles in sex-biased diseases, and therapeutic opportunities.

Authors:  Jianjian Li; Zhe Ming; Liuyi Yang; Tingxuan Wang; Gaowen Liu; Qing Ma
Journal:  Genes Dis       Date:  2022-04-29

Review 4.  The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases.

Authors:  Qinfan Yao; Cuili Wang; Yucheng Wang; Xiuyuan Zhang; Hong Jiang; Dajin Chen
Journal:  Clin Transl Oncol       Date:  2022-08-20       Impact factor: 3.340

Review 5.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

6.  A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.

Authors:  Jing Peng; Yan Hao; Bihua Rao; Zhiguo Zhang
Journal:  Transl Cancer Res       Date:  2021-11       Impact factor: 1.241

Review 7.  Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?

Authors:  Sandra Santos-Sierra
Journal:  Biomolecules       Date:  2021-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.